With the identification of the cystic fibrosis (CF) gene,'2 population carrier detection is a practical possibility and three pilot studies funded by the Cystic Fibrosis Trust are already under way in the UK. The intention of offering such screening to a general population is to inform people of their carrier risk before they give birth to an affected child. This marks a major departure from previous practice in preventive medicine; we have no precedent for screening of this kind in the UK. Although it might be argued that screening programmes for sickle cell conditions, thalassaemia, and Tay-Sachs disease are comparable because they are also autosomal recessive disorders, their occurrence in the UK is mostly restricted to ethnic minority groups, and therefore offers no model for mass screening of the population as a whole. Furthermore, even for these conditions, it is apparent that generalisation is not possible from one disease to another or between different cultural contexts (for instance, compare the examples of thalassaemia in Cyprus3 or London4 with the state of sickle cell screening in the UK5).
We need to know how the population will react to the existence of carrier screening for CF and, arguably, the best way of finding out is to try it and see. From the pilot programmes that are already operating we will discover what percentage of people accept the offer of carrier screening and, it is to be hoped, we will also learn something about the best way to offer it. For example, whether to use buccal scrapings or blood samples, to test at GP surgeries or in antenatal clinics, and whether to invite people to attend for screening or to test opportunistically.
However, there are important questions to be asked that might not be answered by this 'try it and see' approach. These concern underlying attitudes towards genetic disease in general and CF in particular. For example, should screening be compulsory? Is it believed that people have a social responsibility to avoid the birth of handicapped children? What priority should screening for genetic disease have in NHS budgeting? Are people concerned about possible misuse of genetic information? Such questions could, in principle, be asked of people to whom screening is being offered. However, there is a danger that answers would be biased by a need for cognitive consistency on the part of respondents. 6 Those accepting testing might feel a need to be positive about screening, while those declining, even if only for pragmatic reasons (such as inconvenient clinic times), might play down the advantages of screening. Arguably, the best way to obtain information about underlying attitudes is to separate these questions from the practicalities of testing, and to ask them of people who are not being offered screening at that time.
Another reason for taking this latter approach lies in the particular uncertainties of CF screening, especially the uncertain prognosis and the fact that, at best, the test will detect only 85% of carriers. These are features which may be important in people's decision making. Somebody may support the idea of genetic carrier screening for some conditions but not consider the severity of handicap in CF sufficient grounds for avoiding the birth of an affected child. Or, they may want screening because they want the reassurance of knowing that they are not a carrier, in which case they may feel that 85% sensitivity is not good enough. In order to assess these issues, it is necessary first to raise general questions about genetic screening, free from real life practicalities, and then to introduce these considerations subsequently. This paper reports a small scale study which examined attitudes towards genetic screening using this approach.
Methods
Questionnaires were sent to 207 couples who had recently taken part in another questionnaire based study being carried out by our team. This earlier study was of attitudes and experiences concerning prenatal screening7 and the women had filled in questionnaires at three points in pregnancy and at six weeks after delivery. Their partners had not been directly involved in the earlier study, although a number had commented that they would have liked to have had questionnaires of their own to fill in. The women had originally been recruited through nine District General Hospitals, all within 60 miles of Cambridge, when they had registered for antenatal care. At the time when questionnaires were sent for the present study, their babies were between 2 and 5 months old. The questionnaire was not sent if any of the following applied: (1) neonatal death or congenital abnormality in the most recent pregnancy, (2) major maternal health problems since delivery (including depression), (3) no current partner, (4) reports of a poor relationship with partner, (5) not intending to have more children, (6) scored less than 3 on a scale from 0 to 5 in answer to the question "Have you enjoyed taking part in this research?" (0 meaning not at all, 5 meaning very much). This last question came at the end of the questionnaire that was completed six weeks after delivery, and the purpose of the exclusion was to avoid imposing on people who were unlikely to want to participate.
Because of their participation in the earlier study we had a considerable amount of information about the women, including their reproductive histories, attitudes to prenatal screening, attitudes to abortion, personal knowledge of various handicapping conditions, and background information such as age, occupation, and religion. We also had these last three items for the men.
RESPONSE
Questionnaires were returned by 104 women and 71 men (50% and 34%). These are lower response rates than we would have expected considering the 'track record' of the women targetted. Although we cannot know the precise reasons for non-response, we are able to compare responders and non-responders in terms of our pre-existing information about them. This shows that responders tended to be older, better educated, and to have higher status jobs than non-responders. There were no significant differences between responders and non-responders in terms of their religion or attitudes to abortion. One couple (responders), out of the 207 targetted, had had a previous child who was handicapped; two (both non-responders) had had previous children who had died.
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Nearly half the sample said that they would make a special trip to have the test done. This cannot, of course, be taken to be predictive of uptake in practice since this is a self selected sample of people who were interested enough to complete the questionnaire. We might, however, cautiously infer that the 58% of the target group who were not even interested enough to return the questionnaire would be unlikely to want to make a special trip to have the test done. Of the 52 people who said that they would have the test if their partner were found to be a carrier, five women and nine men gave it as their only response. In one case this included both members of a couple! There was one final question. Sachs pregnancies but only 24% gave this response for haemophilia. In that study, however, the options offered to respondents, for example sterilisation, artificial insemination, were somewhat different from those of the present study. Furthermore, the American sample was better educated and better informed about genetics and genetic disease than our sample.
The majority of respondents in this study were positive about the basic aims that genetic carrier screening is intended to achieve, although a number clearly did appreciate some of the problems, particularly the possibility that information might be misused. Arguments in favour of screening were consistently rated as important, and arguments against as relatively unimportant. The striking exception to this trend was with respect to economic arguments: both those for and against were rejected by the majority of the sample, even though the form of the question gave them the freedom to rate these alongside other arguments. Cost was not seen as important even when it could be rated without downgrading other choices. This is consistent with other findings on attitudes to medical care.
The sample also showed their general support for genetic carrier screening in their responses to a hypothetical test that would be "quite straightforward and 100% accurate". Nobody supported the view that such a test "should not be available at all". Once the complex realities of CF carrier screening were introduced, only 60% were prepared to say that it was definitely worth offering in its present form although another 23% thought "possibly". The contrast between these two situations probably accounts for the discrepancy between the current findings and those of earlier studies,810 I' all of which predate recognition of the practical limitations of CF carrier screening and none of which suggested that screening would be other than "quite straightforward and 100% accurate". A survey in the Netherlands,'0 for example, found that 80% of new mothers thought that CF carrier screening should be offered, and the figure was even higher for medical students (96%) and for self selected readers of a local newspaper (90%). In the recently published study of Edinburgh schoolchildren," 86% thought that routine carrier screening should be offered. This may also account for the numbers saying that they would want to be screened. Williamson et al8
found that 84% of their sample said that they would want to know if they were a carrier, while in the Dutch study the percentage saying that they themselves would make use of screening varied from 54% of medical students through 63% of new mothers to 77% of newspaper readers. To what extent can the sample reported here be considered as representative? Firstly we need to ask why the response rate was so low. The sample had been chosen with the expectation of a much higher response rate than that which was actually achieved. Postal studies of pregnant women carried out by our team typically achieve around 70% response initially and nearer 90% on follow up. Furthermore, the women targetted had all shown their willingness to complete questionnaires during the course of their recent pregnancies and only those who said that they had enjoyed taking part were included. The target sample was also limited to those who were likely to have further children, the assumption being that the issues would have greater relevance to this group. So why did not more respond? It may be that they were all too busy with their new babies, or that they felt that they had already done enough for us. All had recently had a healthy child which may have led them to think that they were not themselves at risk, and that the subject was not, therefore, relevant to them. It may also be that the issues were difficult to understand, the questionnaire too long, or simply that the topic did not engage their attention. These latter explanations seem very likely, particularly when we see that most respondents claim to have had a reasonable understanding of the issues raised. Presumably those who did not understand did not respond. This is a problem inherent in any attempt to offer mass screening: the issues are not simple to understand, neither are conditional probabilities, and the long term implications may not be apparent at all.
The hazards of offering CF carrier screening at present have been clearly described by Wilfond and Fost.14 Nevertheless, it is evident that many professionals in the field do not accept all the arguments, especially those relating to the social implications. If professionals have not fully grasped the issues, how then can ordinary lay people be expected to? The results reported in this paper can only be taken as the responses of a minority group who were prepared to grapple with the issues, successfully or otherwise, and not as being representative of all new parents. The problems of ensuring that all potential subjects of carrier screening are making genuinely informed decisions should not be underestimated.
The questionnaire used in this study underwent a number of metamorphoses in the attempt to convey the issues raised by genetic screening to a non-specialist audience. This process was greatly aided by the critical comments of Martin Bobrow, Martin Richards, Helen Statham, and Claire Snowdon, to all of whom I am most grateful.
